John Blankenhorn

John Blankenhorn

InvestorPlace Contributor Expertise: Biochemistry, biotechnology and pharmaceutical research

John Blankenhorn has been a researcher since 2016 and has years of experience and publications on the topics of biochemistry, biotechnology, and pharmaceutical research. His main interests are the application of biology and biotechnology to our daily lives, as well as the use of Machine Learning and AI to speed up research and development in the life sciences. He currently works at Emory University studying the structural basis of Alzheimer’s Disease.

Recent Articles

Ride the Quantum Computing Wave to Riches With These 3 Promising Stock Picks

By John Blankenhorn, InvestorPlace Contributor

Quantum computing is the wave of the future. So here are 3 of the most promising quantum computing stocks to buy.

3 Cheap Battery Stocks That Smart Investors Will Snap Up Now

By John Blankenhorn, InvestorPlace Contributor

The cheapest battery stocks to buy aren't penny stocks. They're companies offering growth, dividend and guaranteed earnings.

Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil

By John Blankenhorn, InvestorPlace Contributor

There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today.

3 Biotech Stocks to Buy Before Drug Trials End

By John Blankenhorn, InvestorPlace Contributor

Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains.

The 3 Best Self-Driving Car Stocks to Buy In July

By John Blankenhorn, InvestorPlace Contributor

Here are 3 self-driving car stocks to add to your portfolio if you see the mode of transportation as the wave of the future.

Load More